Defining appropriateness criteria for endoscopic sinus surgery during management of uncomplicated adult chronic rhinosinusitis: a RAND/UCLA appropriateness study
- PMID: 26934470
- DOI: 10.4193/Rhino16.023
Defining appropriateness criteria for endoscopic sinus surgery during management of uncomplicated adult chronic rhinosinusitis: a RAND/UCLA appropriateness study
Abstract
Introduction: Appropriate indications for endoscopic sinus surgery (ESS) for chronic rhinosinusitis (CRS) are currently poorly defined. The lack of clear surgical indications for ESS likely contributes to the large geographic variation in surgical rates and contributes to reduced quality of care. The objective of this study was to define appropriateness criteria for ESS during management of adult patients with uncomplicated CRS.
Methods: The RAND/UCLA appropriateness methodology was performed. An international, multi-disciplinary panel of 10 experts in CRS was formed and completed two rounds of a modified Delphi ranking process along with a face-to-face meeting.
Results: A total of 624 clinical scenarios were ranked, 312 scenarios each for CRS with and CRS without nasal polyps. For adult patients with uncomplicated CRS with nasal polyps, ESS can be appropriately offered when the CT Lund-Mackay score is ≥ 1 and there has been a minimum trial of a topical intranasal corticosteroid plus a short-course of systemic corticosteroid with a post-treatment total SNOT-22 score ≥ 20. For adult patients with uncomplicated CRS without nasal polyps, ESS can be appropriately offered when the CT Lund-Mackay score is ≥ 1 and there has been a minimum trial of a topical intranasal corticosteroid plus either a short-course of a broad spectrum/culture-directed systemic antibiotic or the use of a prolonged course of systemic low-dose anti-inflammatory antibiotic with a post-treatment total SNOT-22 score ≥ 20.
Conclusion: This study has developed and reported of list of appropriateness criteria to offer ESS as a treatment option during management of uncomplicated adult CRS. The extent or technique of ESS was not addressed in this study and will depend on surgeon and patient factors. Furthermore, these criteria are the minimal threshold to make ESS a treatment option and do not imply that all patients meeting these criteria require surgery. The decision to perform ESS should be made after an informed patient makes a preference-sensitive decision to proceed with surgery. Applying these appropriateness criteria for ESS may optimize patient selection, reduce the incidence of unwarranted surgery, and assist clinicians in providing high quality, patient-centered care to patients with CRS.
Similar articles
-
Defining appropriateness criteria for endoscopic sinus surgery during management of uncomplicated adult chronic rhinosinusitis: a RAND/UCLA appropriateness study.Int Forum Allergy Rhinol. 2016 Jun;6(6):557-67. doi: 10.1002/alr.21769. Epub 2016 Mar 11. Int Forum Allergy Rhinol. 2016. PMID: 26970538
-
Indications and Outcomes for Patients With Limited Symptoms Undergoing Endoscopic Sinus Surgery.Am J Rhinol Allergy. 2020 Jul;34(4):502-507. doi: 10.1177/1945892420912159. Epub 2020 Mar 13. Am J Rhinol Allergy. 2020. PMID: 32168996
-
Appropriateness Criteria for Surgery in the Management of Adult Recurrent Acute Rhinosinusitis.Laryngoscope. 2019 Jan;129(1):37-44. doi: 10.1002/lary.27438. Epub 2018 Oct 3. Laryngoscope. 2019. PMID: 30284272
-
When are we operating for chronic rhinosinusitis? A systematic review of maximal medical therapy protocols prior to endoscopic sinus surgery.Int Forum Allergy Rhinol. 2015 Dec;5(12):1095-103. doi: 10.1002/alr.21601. Epub 2015 Jul 22. Int Forum Allergy Rhinol. 2015. PMID: 26201538
-
Systematic Review and Meta-analysis of SNOT-22 Outcomes after Surgery for Chronic Rhinosinusitis with Nasal Polyposis.Otolaryngol Head Neck Surg. 2018 Sep;159(3):414-423. doi: 10.1177/0194599818773065. Epub 2018 May 1. Otolaryngol Head Neck Surg. 2018. PMID: 29712509
Cited by
-
Real-life assessment of chronic rhinosinusitis patients using mobile technology: The mySinusitisCoach project by EUFOREA.Allergy. 2020 Nov;75(11):2867-2878. doi: 10.1111/all.14408. Epub 2020 Jun 19. Allergy. 2020. PMID: 32424899 Free PMC article.
-
[Dupilumab has an additional benefit in treatment of chronic rhinosinusitis with nasal polyps].HNO. 2021 Nov;69(11):868-877. doi: 10.1007/s00106-021-01018-z. Epub 2021 Mar 18. HNO. 2021. PMID: 33738558 Free PMC article. Review. German.
-
Assessing the Use of Patient-Reported Outcome Measures in the Routine Clinical Care of Chronic Rhinosinusitis Patients: A Canadian Perspective.J Otolaryngol Head Neck Surg. 2024 Jan-Dec;53:19160216241288806. doi: 10.1177/19160216241288806. J Otolaryngol Head Neck Surg. 2024. PMID: 39415404 Free PMC article.
-
Positionspapier: Empfehlungen zur Behandlung der chronischen Rhinosinusitis während der COVID-19-Pandemie im deutschen Gesundheitssystem – Empfehlungen des Ärzteverbandes Deutscher Allergologen (AeDA) und der Deutschen Gesellschaft für HNO-Heilkunde, Kopf- und Halschirurgie (DGHNO-KHC) – Diese Empfehlungen basieren auf dem EAACI Positionspapier „Treatment of chronic RhinoSinusitis with nasal polyps (CRSwNP) in the COVID-19 pandemics – An EAACI Position Paper”, Allergy, 2020 und wurden auf die Situation im deutschen Gesundheitswesen angepasst.Laryngorhinootologie. 2020 Jun;99(6):356-364. doi: 10.1055/a-1164-9696. Epub 2020 May 8. Laryngorhinootologie. 2020. PMID: 32384572 Free PMC article. German.
-
The treatment efficacy of nasal polyposis on olfactory functions, clinical scoring systems and inflammation markers.Eur Arch Otorhinolaryngol. 2019 Dec;276(12):3367-3372. doi: 10.1007/s00405-019-05619-x. Epub 2019 Aug 31. Eur Arch Otorhinolaryngol. 2019. PMID: 31473779
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical